Patent 10927385 was granted and assigned to Inscripta on February, 2021 by the United States Patent and Trademark Office.
The present disclosure provides methods to increase the percentage of edited yeast cells in a cell population using nucleic-acid guided editing, and automated multi-module instruments for performing these methods.